Biliary transport of irinotecan and metabolites in normal and P-glycoprotein-deficient mice

Cancer Chemotherapy and Pharmacology
L IyerUlrich Mayer

Abstract

The extensive and unpredictable biliary excretion of CPT-11 and its metabolites, SN-38 and SN-38 glucuronide (SN-38G) may contribute to the wide interpatient variability reported in the disposition and gastrointestinal toxicity of CPT-11. We studied the role of P-glycoprotein (P-gp) in in vivo biliary excretion of CPT-11, SN-38 and SN-38G in mice lacking mdr1-type P-gp [ mdr1a/1b(-/-)] in the presence of the multidrug resistance (MDR) reversal agent, PSC833. Wild-type (Wt) and mdr1a/1b(-/-) mice ( n=3 or 4) were treated intragastrically with PSC833 (50 mg/kg) or vehicle 2 h prior to i.v. CPT-11 dosing (10 mg/kg), and bile samples were collected. P-gp was found to play an important role in CPT-11 biliary excretion, as there was a significant (40%, P<0.05) decrease in its biliary recovery in 90 min in mdr1a/1b(-/-) mice (6.6+/-0.6% dose) compared with Wt mice (11+/-1.2%). This also implied a major role of other undetermined non-P-gp-mediated mechanism(s) for hepatic transport of CPT-11, which was inhibited by PSC833 (1.8+/-0.8% with PSC833, 6.6+/-0.6% without PSC833) in mdr1a/1b(-/-) mice. SN-38 and SN-38G biliary transport was unchanged in mice lacking P-gp after vehicle treatment, indicating a lack of P-gp mediation in their tr...Continue Reading

Citations

Jan 22, 2003·Advanced Drug Delivery Reviews·Yan ZhangDonald W Miller
May 6, 2003·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Alex SparreboomWilliam D Figg
Sep 23, 2009·Anti-cancer Drugs·Christoph SchulzHans-Joachim Stemmler
Sep 1, 2004·Pharmacogenomics·Giuseppe Toffoli, Erika Cecchin
Aug 7, 2008·Pharmacogenomics·Silvia FunkeJenny Chang-Claude
Mar 20, 2010·Pharmacogenomics·Yutaka Fujiwara, Hironobu Minami
Jan 11, 2005·The Journal of Pharmacy and Pharmacology·Peter J TobinAndrew J McLachlan
Jan 13, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Tripta BansalSushama Talegaonkar
Jan 29, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Ji-Youn HanJin Soo Lee
Apr 2, 2005·British Journal of Clinical Pharmacology·Qingyu ZhouBalram Chowbay
Jul 18, 2006·Pharmacology & Therapeutics·Mary Treinen-Moslen, Mary F Kanz
Nov 8, 2005·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Nicola F SmithAlex Sparreboom
May 1, 2012·Biomolecules & Therapeutics·Eun-Young KwakWon-Sik Shim
Mar 31, 2012·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Jason A SprowlAlex Sparreboom
Jan 2, 2014·Toxicology and Applied Pharmacology·Elisabeth FilipskiAlper Okyar
Dec 28, 2011·Drug Metabolism and Pharmacokinetics·Yuko AkiyamaYasutsuna Sasaki
Feb 24, 2009·Journal of Pharmacological Sciences·Takanori AkagiShigehiro Ohdo
Mar 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John D ChesterMatthew T Seymour
Aug 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael MichaelJohn R Zalcberg
Aug 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Deanna L Kroetz
Jul 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe ToffoliSergio Frustaci
Feb 17, 2017·Biopharmaceutics & Drug Disposition·Emilie HéninMichel Tod
Apr 13, 2007·Expert Review of Anticancer Therapy·Michael S BraunMatthew T Seymour
Aug 19, 2014·World Journal of Gastroenterology : WJG·Beatrice Mohelnikova-DuchonovaPavel Soucek
Mar 22, 2015·Journal of Neuro-oncology·Lauriane GoldwirtChristine Fernandez
Apr 2, 2020·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Xia GongLingzhi Gong
Jan 27, 2015·Journal of Veterinary Internal Medicine·K L Mealey, J Fidel
Nov 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Samir E WittaS Gail Eckhardt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.